Results 211 to 220 of about 109,064 (360)
Ipsilateral hemi-parkinsonism secondary to an astrocytoma. [PDF]
A Kulali, M Tugtekin, Y Utkur, S Erkurt
openalex +1 more source
Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience
Abstract Objective Several antiseizure medications (ASMs) can be considered as first‐line treatment for glioma‐associated epilepsy (GAE). We aimed to find out, if there are subgroups of glioma patients which may benefit from different first‐line ASMs. Methods All diffuse glioma (grade 2–4) patients, who were in contact with Helsinki University Hospital
Leena Ollila, Reina Roivainen
wiley +1 more source
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
A. Fontebasso+47 more
semanticscholar +1 more source
What's new? This population‐based case‐control study quantifies the risk of childhood brain tumors following exposure to radiation from computed tomography scans in Finland. Leveraging comprehensive nationwide cancer and computed tomography data and addressing key limitations in previous research, including reverse causation and confounding by ...
Jad Abuhamed+4 more
wiley +1 more source
HMGA2 is an independent prognostic indicator and a potential therapeutic target for IDH-mutant astrocytoma. [PDF]
Wan L, Liu Z, Li S, Gao Z.
europepmc +1 more source
Background Epilepsy is the most common preoperative symptom in patients with supratentorial gliomas. Identifying tumor locations and clinical factors associated with preoperative epilepsy is important for understanding seizure risk. Purpose To investigate the key brain areas and risk factors associated with preoperative seizures in glioma patients ...
Tianshi Li+4 more
wiley +1 more source
Persistent symmetrical white matter hyperintensities: a case report. [PDF]
Paranavitane SA+4 more
europepmc +1 more source
Background Edited MRS technique such as MEshcher‐GArwood Point RESolved Spectroscopy (MEGA‐PRESS) can determine isocitrate dehydrogenase mutation (IDH) mutation status in patients with gliomas but its accuracy in assessing glioma grade has not yet been formally evaluated.
Maria L. Brun‐Vergara+10 more
wiley +1 more source